COMPOSITION AND METABOLISM OF HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS

被引:72
作者
SCHAEFER, EJ
FOSTER, DM
JENKINS, LL
LINDGREN, FT
BERMAN, M
LEVY, RI
BREWER, HB
机构
[1] Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
关键词
D O I
10.1007/BF02533471
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The composition and metabolism of high density lipoprotein (HDL) subfractions were investigated in seven nomal individuals. Mean HDL2 (d, 1.063-1.125 g/ml) composition (by weight) was 43% protein, 28% phospholipid, 23% cholesterol, and 6% triglyceride, and mean HDL3 (d, 1.125-1.21 g/ml) composition was 58% protein, 22% phospholipid, 14% cholesterol, and 5% triglyceride. The mean apoA-I; apoA-II weight ratio was 4.75 for HDL2 and 3.65 for HDL3.HDL2 protein was proportionally slightly richer in C apolipoproteins and higher molecular weight constituents (including apoE) than HDL3. Kinetic studies utilizing radiolabeled HDLA (d, 1.09-1.21 g/ml), HDL2, and HDL3 demonstrated rapid exchange of apoA-I and apoA-II radioactivity among HDL subfractions, similar fractional rates of catabolism of apoA-I and apoA-II within HDL, and similar radioactivity decay within HDL subfractions. Mean plasma residence time was 5.74 days for radiolabeled HDL2 and 5.70 days for radiolabeled HDL3. Differences in HDL protein mass among individuals were largely due to alterations in catabolism, and in general both HDL2 and HDL3 were catabolized via a plasma and a nonplasma pathway. Data from simultaneous radiolabeled very low density lipoprotein and HDL studies in 2 individuals are consistent with the concept that apoC-II and apoC-III are catabolized at a different rate than are apoA-I and apoA-II within the HDL density range. © 1979 American Oil Chemists' Society.
引用
收藏
页码:511 / 522
页数:12
相关论文
共 56 条
[11]   HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772
[12]   MEASUREMENT OF APOLIPOPROTEIN A-I AND A-II LEVELS IN MEN AND WOMEN BY IMMUNOASSAY [J].
CHEUNG, MC ;
ALBERS, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :43-50
[13]   DETERMINATION OF HUMAN APO-LIPOPROTEIN-E BY ELECTRO-IMMUNOASSAY [J].
CURRY, MD ;
MCCONATHY, WJ ;
ALAUPOVIC, P ;
LEDFORD, JH ;
POPOVIC, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 439 (02) :413-425
[14]  
CURRY MD, 1976, CLIN CHEM, V22, P315
[15]  
DELAHUNTY T, 1975, J BIOL CHEM, V250, P2718
[16]  
DELALLA OF, 1954, METHOD BIOCHEM ANAL, V1, P459
[17]  
FELKER TE, 1977, J LIPID RES, V18, P465
[18]   PROTEIN COFACTOR OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE [J].
FIELDING, CJ ;
FIELDING, PE ;
SHORE, VG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 46 (04) :1493-&
[19]  
FORMISANO S, 1978, J BIOL CHEM, V253, P354
[20]  
FRIEDBERG SJ, 1976, J BIOL CHEM, V251, P4005